Harrow (HROW) Depreciation and Depletion (2010 - 2024)
Harrow's (HROW) quarterly Depreciation and Depletion came in at $351000.0 in Q3 2024, up 21.03% year-on-year from $290000.0 in Q4 2023, and up 16.61% quarter-over-quarter from $301000.0 in Q2 2024.
Harrow (HROW) Depreciation and Depletion (2010 - 2024) Analysis & Trends
Harrow's Depreciation and Depletion history runs 11 years deep, the most recent figure standing at $351000.0 for Q3 2024.
- On a quarterly basis, Depreciation and Depletion rose 21.03% year-over-year to $351000.0 in Q3 2024; TTM through Sep 2024 was $1.2 million, a 28.01% increase from a year earlier, with the FY2017 full-year figure at $1.4 million, up 32.8% from the prior year.
- Depreciation and Depletion climbed to $351000.0 in Q3 2024 per HROW's latest filing, from $301000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $436000.0 in Q1 2021 and bottomed at $171000.0 in Q3 2022.
- The 4-year median for Depreciation and Depletion is $351000.0 (2024), against an average of $320909.1.
- Across the five-year window, Depreciation and Depletion plunged 58.29% in 2022 and soared 69.59% in 2023, its largest moves.
- Year by year, Depreciation and Depletion stood at $410000.0 in 2021, then slumped by 58.29% to $171000.0 in 2022, then surged by 69.59% to $290000.0 in 2023, then climbed by 21.03% to $351000.0 in 2024.
- Per Business Quant, the three latest HROW Depreciation and Depletion figures stand at $351000.0 (Q3 2024), $301000.0 (Q2 2024), and $290000.0 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 351,000.00 |
| Sep 30, 2024 | 351,000.00 |
| Jun 30, 2024 | 301,000.00 |
| Jun 30, 2024 | 301,000.00 |
| Sep 30, 2023 | 290,000.00 |
| Sep 30, 2023 | 290,000.00 |
| Jun 30, 2023 | 228,000.00 |
| Jun 30, 2023 | 228,000.00 |
| Mar 31, 2023 | 225,000.00 |
| Mar 31, 2023 | 225,000.00 |
| Sep 30, 2022 | 171,000.00 |
| Sep 30, 2022 | 171,000.00 |
| Jun 30, 2022 | 381,000.00 |
| Jun 30, 2022 | 381,000.00 |
| Mar 31, 2022 | 376,000.00 |
| Mar 31, 2022 | 376,000.00 |
| Sep 30, 2021 | 410,000.00 |
| Sep 30, 2021 | 410,000.00 |
| Jun 30, 2021 | 361,000.00 |
| Jun 30, 2021 | 361,000.00 |